• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 exoRBase 数据库构建和分析与卵巢癌相关的竞争性内源 RNA 网络和预后模型。

Construction and analysis of competitive endogenous RNA networks and prognostic models associated with ovarian cancer based on the exoRBase database.

机构信息

Department of Medicine, Xinglin College, Nantong University, Nantong City, Jiangsu Province, China.

Department of Gynecology, Taicang Affiliated Hospital of Soochow University (The First People's Hospital of Taicang), Suzhou City, Jiangsu Province, China.

出版信息

PLoS One. 2024 Apr 11;19(4):e0291149. doi: 10.1371/journal.pone.0291149. eCollection 2024.

DOI:10.1371/journal.pone.0291149
PMID:38603733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11008902/
Abstract

OBJECTIVE

To construct a competitive endogenous RNA (ceRNA) regulatory network in blood exosomes of patients with ovarian cancer (OC) using bioinformatics and explore its pathogenesis.

METHODS

The exoRbase2.0 database was used to download blood exosome gene sequencing data from patients OC and normal controls and the expression profiles of exosomal mRNA, long non-coding RNA (lncRNA), and circular RNA (circRNA) were detected independently using R language for differential expression analysis. TargetScan and miRanda databases were combined for the prediction and differential expression of mRNA-binding microRNAs (miRNA). The miRcode and starBase databases were used to predict miRNAs that bind to differentially expressed lncRNAs and circRNAs repectively. The relevant mRNA, circRNA, lncRNA and their corresponding miRNA prediction data were imported into Cytoscape software for visualization of the ceRNA network. The R language and KEGG Orthology-based Annotation System (KOBAS) were used to execute and illustrate the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Hub genes were identified using The CytoHubba plugin.

RESULTS

Thirty-one differentially expressed mRNAs, 17 differentially expressed lncRNAs, and 24 differentially expressed circRNAs were screened. Cytoscape software was used to construct the ceRNA network with nine mRNA nodes, two lncRNA nodes, eight circRNA nodes, and 51 miRNA nodes. Both GO and KEGG were focused on the Spliceosome pathway, indicating that spliceosomes are closely linked with the development of OC, while heterogenous nuclear ribonucleoprotein K and RNA binding motif protein X-linked genes were the top 10 score Hub genes screened by Cytoscape software, including two lncRNAs, four mRNAs, and four circRNAs. In patients with OC, the expression of eukaryotic translation initiation factor 4 gamma 2 (EIF4G2), SERPINE 1 mRNA binding protein 1 (SERBP1), ribosomal protein L15 (RPL15) and human leukocyte antigen complex P5 (HCP5) was significantly higher whereas that of testis expressed transcript, Y-linked 15 and DEAD-box helicase 3 Y-linked genes was lower compared to normal controls Immunocorrelation scores revealed that SERBP1 was significantly and negatively correlated with endothelial cells and CD4+ T cells and positively correlated with natural killer (NK) cells and macrophages, respectively; RPL15 was significantly positively correlated with macrophages and endothelial cells and negatively correlated with CD8+ T cells and uncharacterized cells, respectively. EIF4G2 was significantly and negatively correlated with endothelial cells and CD4+ T cells, and positively correlated with uncharacterized cells, respectively. Based on the survival data and the significant correlation characteristics derived from the multifactorial Cox analysis (P < 0.05), the survival prediction curves demonstrated that the prognostic factors associated with 3-year survival in patients with OC were The prognostic factors associated with survival were Macrophage, RPL15.

CONCLUSION

This study successfully constructs a ceRNA regulatory network in blood exosomes of OV patients, which provides the specific targets for diagnosis and treatment of OC.

摘要

目的

利用生物信息学构建卵巢癌(OC)患者血液外泌体中的竞争性内源性 RNA(ceRNA)调控网络,并探讨其发病机制。

方法

使用 exoRbase2.0 数据库从 OC 患者和正常对照者的血液外泌体基因测序数据中下载数据,并分别使用 R 语言进行差异表达分析检测外泌体 mRNA、长链非编码 RNA(lncRNA)和环状 RNA(circRNA)的表达谱。结合 TargetScan 和 miRanda 数据库进行 mRNA-结合微小 RNA(miRNA)的预测和差异表达分析。使用 miRcode 和 starBase 数据库分别预测与差异表达 lncRNA 和 circRNA 结合的 miRNA。将相关 mRNA、circRNA、lncRNA 及其相应 miRNA 的预测数据导入 Cytoscape 软件,可视化 ceRNA 网络。使用 R 语言和基于京都基因与基因组百科全书(KEGG)同源注释系统(KOBAS)进行基因本体论(GO)和 KEGG 富集分析。使用 The CytoHubba 插件识别 Hub 基因。

结果

筛选出 31 个差异表达的 mRNAs、17 个差异表达的 lncRNAs 和 24 个差异表达的 circRNAs。使用 Cytoscape 软件构建了 ceRNA 网络,其中包含 9 个 mRNA 节点、2 个 lncRNA 节点、8 个 circRNA 节点和 51 个 miRNA 节点。GO 和 KEGG 都集中在剪接体途径上,表明剪接体与 OC 的发展密切相关,而异质性核核糖核蛋白 K 和 RNA 结合基序蛋白 X 连锁基因是 Cytoscape 软件筛选出的前 10 个得分 Hub 基因,包括 2 个 lncRNA、4 个 mRNAs 和 4 个 circRNAs。在 OC 患者中,真核起始因子 4 伽马 2(EIF4G2)、丝氨酸蛋白酶抑制剂 1 mRNA 结合蛋白 1(SERBP1)、核糖体蛋白 L15(RPL15)和人白细胞抗原复合物 P5(HCP5)的表达明显高于正常对照组;而睾丸表达转录物、Y 连锁 15 和 DEAD 盒螺旋酶 3 Y 连锁基因的表达明显低于正常对照组。免疫相关评分显示,SERBP1 与内皮细胞和 CD4+T 细胞呈显著负相关,与自然杀伤(NK)细胞和巨噬细胞呈显著正相关;RPL15 与巨噬细胞和内皮细胞呈显著正相关,与 CD8+T 细胞和未鉴定细胞呈显著负相关。EIF4G2 与内皮细胞和 CD4+T 细胞呈显著负相关,与未鉴定细胞呈显著正相关。基于生存数据和多因素 Cox 分析得出的显著相关性特征(P<0.05),生存预测曲线表明,与 OC 患者 3 年生存率相关的预后因素为:预后因素为巨噬细胞、RPL15。

结论

本研究成功构建了 OC 患者血液外泌体中的 ceRNA 调控网络,为 OC 的诊断和治疗提供了特定的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/31f42b9cb0b7/pone.0291149.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/6302e2057994/pone.0291149.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/ac1ab5c10f85/pone.0291149.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/418200d5dc62/pone.0291149.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/b6788f4d1019/pone.0291149.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/7e6ebd29bfe1/pone.0291149.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/334c271cb243/pone.0291149.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/8e9188a54051/pone.0291149.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/69d06967e067/pone.0291149.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/2743e9f14e9f/pone.0291149.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/1ca4be91ad6f/pone.0291149.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/31f42b9cb0b7/pone.0291149.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/6302e2057994/pone.0291149.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/ac1ab5c10f85/pone.0291149.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/418200d5dc62/pone.0291149.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/b6788f4d1019/pone.0291149.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/7e6ebd29bfe1/pone.0291149.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/334c271cb243/pone.0291149.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/8e9188a54051/pone.0291149.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/69d06967e067/pone.0291149.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/2743e9f14e9f/pone.0291149.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/1ca4be91ad6f/pone.0291149.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7047/11008902/31f42b9cb0b7/pone.0291149.g011.jpg

相似文献

1
Construction and analysis of competitive endogenous RNA networks and prognostic models associated with ovarian cancer based on the exoRBase database.基于 exoRBase 数据库构建和分析与卵巢癌相关的竞争性内源 RNA 网络和预后模型。
PLoS One. 2024 Apr 11;19(4):e0291149. doi: 10.1371/journal.pone.0291149. eCollection 2024.
2
Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.基于血液外泌体 ceRNA 网络构建胰腺导管腺癌患者生存预测模型并验证。
BMC Med Genomics. 2022 Dec 15;15(1):260. doi: 10.1186/s12920-022-01409-3.
3
Analysis of Competitive Endogenous RNA Regulatory Network of Exosomal Breast Cancer Based on exoRBase.基于外显子RNA数据库(exoRBase)的外泌体乳腺癌竞争性内源性RNA调控网络分析
Evol Bioinform Online. 2022 Jul 20;18:11769343221113286. doi: 10.1177/11769343221113286. eCollection 2022.
4
Identification of a lncRNA/circRNA-miRNA-mRNA ceRNA Network in Alzheimer's Disease.鉴定阿尔茨海默病中的 lncRNA/circRNA-miRNA-mRNA ceRNA 网络。
J Integr Neurosci. 2023 Oct 17;22(6):136. doi: 10.31083/j.jin2206136.
5
Construction of endogenous RNA regulatory network for colorectal cancer based on bioinformatics.基于生物信息学构建结直肠癌内源性 RNA 调控网络。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Apr 28;47(4):416-430. doi: 10.11817/j.issn.1672-7347.2022.210532.
6
Identification of a Plasma Exosomal lncRNA- and circRNA-Based ceRNA Regulatory Network in Patients With Lung Adenocarcinoma.肺腺癌患者血浆外泌体 lncRNA 和 circRNA 基于 ceRNA 调控网络的鉴定。
Clin Respir J. 2024 Oct;18(10):e70026. doi: 10.1111/crj.70026.
7
[Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].[与胃癌相关的竞争性内源性RNA调控网络的构建与分析]
Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):115-121. doi: 10.3760/cma.j.issn.0253-3766.2020.02.006.
8
mRNA, lncRNA and Circular RNA Expression Profiles in Granulosa Cells of Infertile Women with Ovarian Endometriosis.卵巢子宫内膜异位症不孕女性颗粒细胞中的mRNA、lncRNA和环状RNA表达谱
Reprod Sci. 2022 Oct;29(10):2937-2946. doi: 10.1007/s43032-022-00966-3. Epub 2022 Jul 7.
9
Construction and functional enrichment analysis of the competitive endogenous RNA regulatory network for nonarteritic anterior ischemic optic neuropathy based on high-throughput sequencing.基于高通量测序的非动脉炎性前部缺血性视神经病变竞争性内源性RNA调控网络的构建及功能富集分析
Funct Integr Genomics. 2022 Dec;22(6):1253-1267. doi: 10.1007/s10142-022-00914-z. Epub 2022 Nov 10.
10
CircRNA, lncRNA, and mRNA profiles of umbilical cord blood exosomes from preterm newborns showing bronchopulmonary dysplasia.早产儿支气管肺发育不良患儿脐血外泌体中 circRNA、lncRNA 和 mRNA 谱。
Eur J Pediatr. 2022 Sep;181(9):3345-3365. doi: 10.1007/s00431-022-04544-2. Epub 2022 Jul 5.

本文引用的文献

1
LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer.长链非编码RNA HCP5编码蛋白通过调控铁死亡促进三阴性乳腺癌进展
Cancers (Basel). 2023 Mar 21;15(6):1880. doi: 10.3390/cancers15061880.
2
Specific mechanisms of translation initiation in higher eukaryotes: the eIF4G2 story.真核生物翻译起始的特定机制:eIF4G2 的故事。
RNA. 2023 Mar;29(3):282-299. doi: 10.1261/rna.079462.122. Epub 2022 Dec 14.
3
High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer.
由TUG1/Hsa-miR-26a-5p轴介导的EIF4G2高表达与胃癌的不良预后和免疫浸润相关。
J Oncol. 2022 Sep 16;2022:9342283. doi: 10.1155/2022/9342283. eCollection 2022.
4
Long noncoding RNA HCP5 promotes osteosarcoma cell proliferation, invasion, and migration via the miR-29b-3p-LOXL2 axis.长链非编码RNA HCP5通过miR-29b-3p-LOXL2轴促进骨肉瘤细胞的增殖、侵袭和迁移。
Kaohsiung J Med Sci. 2022 Oct;38(10):960-970. doi: 10.1002/kjm2.12577. Epub 2022 Jul 28.
5
Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer.外泌体非编码RNA在卵巢癌中的新兴功能及临床应用
Front Oncol. 2021 Nov 5;11:765458. doi: 10.3389/fonc.2021.765458. eCollection 2021.
6
Exosome long non-coding RNA SOX2-OT contributes to ovarian cancer malignant progression by miR-181b-5p/SCD1 signaling.外泌体长链非编码 RNA SOX2-OT 通过 miR-181b-5p/SCD1 信号通路促进卵巢癌恶性进展。
Aging (Albany NY). 2021 Oct 24;13(20):23726-23738. doi: 10.18632/aging.203645.
7
LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β-catenin/cyclin D1 signaling via PLAGL2.长链非编码RNA HCP5作为miR-128-3p的海绵,通过PLAGL2激活Wnt/β-连环蛋白/细胞周期蛋白D1信号通路,促进多发性骨髓瘤的进展。
Cell Biol Toxicol. 2022 Dec;38(6):979-993. doi: 10.1007/s10565-021-09628-7. Epub 2021 Jul 31.
8
[Research Progress on Exosome in Malignant Tumors].[外泌体在恶性肿瘤中的研究进展]
Zhongguo Fei Ai Za Zhi. 2020 Aug 20;23(8):689-694. doi: 10.3779/j.issn.1009-3419.2020.101.28.
9
Ovarian Cancer: An Overview.卵巢癌概述。
Radiol Technol. 2020 Jul;91(6):561-575.
10
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.靶向肿瘤干细胞克服卵巢癌的治疗抵抗。
Cells. 2020 Jun 4;9(6):1402. doi: 10.3390/cells9061402.